WO2006019881A3 - Compositions and methods for controlling biofilms and bacterial infections - Google Patents

Compositions and methods for controlling biofilms and bacterial infections Download PDF

Info

Publication number
WO2006019881A3
WO2006019881A3 PCT/US2005/024945 US2005024945W WO2006019881A3 WO 2006019881 A3 WO2006019881 A3 WO 2006019881A3 US 2005024945 W US2005024945 W US 2005024945W WO 2006019881 A3 WO2006019881 A3 WO 2006019881A3
Authority
WO
WIPO (PCT)
Prior art keywords
controlling
bacterial infections
methods
compositions
biofilms
Prior art date
Application number
PCT/US2005/024945
Other languages
French (fr)
Other versions
WO2006019881A2 (en
Inventor
Gary R Eldridge
Matt Goering
Original Assignee
Gary R Eldridge
Matt Goering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/085,279 external-priority patent/US7604978B2/en
Priority claimed from US11/133,858 external-priority patent/US20060264411A1/en
Application filed by Gary R Eldridge, Matt Goering filed Critical Gary R Eldridge
Publication of WO2006019881A2 publication Critical patent/WO2006019881A2/en
Publication of WO2006019881A3 publication Critical patent/WO2006019881A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides compounds and compositions useful for controlling bacterial biofilms as well as for controlling and/or preventing bacterial infections. The compounds of the invention are pentacyclic acid triterpenes. Methods for controlling biofilms and for controlling and/or preventing bacterial infections are also disclosed.
PCT/US2005/024945 2004-07-14 2005-07-14 Compositions and methods for controlling biofilms and bacterial infections WO2006019881A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US58768004P 2004-07-14 2004-07-14
US60/587,680 2004-07-14
US60976304P 2004-09-14 2004-09-14
US60/609,763 2004-09-14
US11/085,279 2005-03-21
US11/085,279 US7604978B2 (en) 2004-07-14 2005-03-21 Inhibition of biofilm formation
US11/133,858 2005-05-20
US11/133,858 US20060264411A1 (en) 2005-05-20 2005-05-20 Control of biofilm formation

Publications (2)

Publication Number Publication Date
WO2006019881A2 WO2006019881A2 (en) 2006-02-23
WO2006019881A3 true WO2006019881A3 (en) 2006-09-08

Family

ID=35785807

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2005/024945 WO2006019881A2 (en) 2004-07-14 2005-07-14 Compositions and methods for controlling biofilms and bacterial infections
PCT/US2005/024946 WO2006010147A2 (en) 2004-07-14 2005-07-14 Control of biofilm formation

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2005/024946 WO2006010147A2 (en) 2004-07-14 2005-07-14 Control of biofilm formation

Country Status (3)

Country Link
EP (1) EP1773313A4 (en)
CA (1) CA2573494A1 (en)
WO (2) WO2006019881A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7604978B2 (en) 2004-07-14 2009-10-20 Sequoia Sciences, Inc. Inhibition of biofilm formation
EP1797108A1 (en) 2004-09-14 2007-06-20 Gary R. Eldridge Compounds, compositions and methods for controlling biofilms and bacterial infections
TWI413646B (en) * 2010-09-03 2013-11-01 Univ China Medical Pharmaceutical composition for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen and uses of the same
CN102784096B (en) * 2011-05-18 2016-10-12 上海现代药物制剂工程研究中心有限公司 A kind of Asiatic acid self-microemulsifyindrug drug delivery system and preparation method thereof
US8324264B1 (en) 2011-07-22 2012-12-04 Sequoia Sciences, Inc. Inhibitors of bacterial biofilms and related methods
WO2013021258A1 (en) * 2011-08-05 2013-02-14 Council Of Scientific & Industrial Research Anti-tubercular compounds
EP2712863B1 (en) * 2012-09-28 2014-10-22 Sequoia Sciences, Inc. Novel inhibitors of bacterial biofilms and related methods
BR112015012960B1 (en) * 2012-12-06 2022-10-11 Colgate-Palmolive Company ORAL GEL FOR TOOTH PAIN RELIEF, ITS PREPARATION METHOD AND ITS USE
CN108358991B (en) * 2018-02-01 2020-11-10 云南中烟工业有限责任公司 Triterpenoid in chengshuanghua, and preparation method and application thereof
CN110141572B (en) * 2019-06-20 2020-05-12 牡丹江医学院 Medicine for treating asthma and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264926B1 (en) * 1999-02-12 2001-07-24 Council Of Scientific And Industrial Research Formulation useful as a natural herbal tooth powder
US6468549B1 (en) * 1996-06-28 2002-10-22 L'oreal Acidic compositions or dermatological composition containing a crosslinked poly (2-acrylamido-2-methylpropanesulfonic acid) neutralized to at least 90%
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985601A (en) * 1995-06-05 1999-11-16 Human Genome Sciences, Inc. DNA encoding human cystatin E

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468549B1 (en) * 1996-06-28 2002-10-22 L'oreal Acidic compositions or dermatological composition containing a crosslinked poly (2-acrylamido-2-methylpropanesulfonic acid) neutralized to at least 90%
US6264926B1 (en) * 1999-02-12 2001-07-24 Council Of Scientific And Industrial Research Formulation useful as a natural herbal tooth powder
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
US20040136924A1 (en) * 2002-12-30 2004-07-15 Boyd Thomas J. Oral care compositions and methods

Also Published As

Publication number Publication date
WO2006010147A3 (en) 2006-07-06
EP1773313A4 (en) 2007-11-07
WO2006019881A2 (en) 2006-02-23
WO2006010147A2 (en) 2006-01-26
EP1773313A2 (en) 2007-04-18
CA2573494A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
WO2006019881A3 (en) Compositions and methods for controlling biofilms and bacterial infections
WO2007127834A3 (en) Compositions and methods of preparation thereof
WO2009146218A8 (en) Compounds including an anti-inflammatory pharmacore and methods of use
MX2007005221A (en) Ascomycin crystalline forms and preparation thereof.
WO2006119295A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP1941799A3 (en) Nematicidal compositions
WO2007028135A3 (en) Imidazopyridine compounds
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
WO2008067219A3 (en) Quinazolinone modulators of tgr5
WO2006092213A8 (en) Pyrazolylcarboxanilides
WO2006050161A3 (en) Therapeutic furopyrimidines and thienopyrimidines
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2006060618A3 (en) Topical nepafenac formulations
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2009042114A3 (en) Phenazine derivatives and uses thereof
WO2006072615A3 (en) Triazolophthalazines as pde2-inhibitors
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
WO2006024640A3 (en) Triazolophthalazines
WO2006120563A3 (en) Antibacterial agents
WO2007070613A3 (en) Rifamycin analogs and uses thereof
WO2008027600A3 (en) Imatinib compositions
WO2007097981A3 (en) Alpha carbolines and uses thereof
WO2008045507A3 (en) Substituted tetracycline compounds for treatment of bacillus anthracis infections
WO2005105079A3 (en) Novel imidazoles
WO2007067784A3 (en) Liposomal compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase